S. Guler Et Al. , "Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus," DIABETES OBESITY & METABOLISM , vol.2, no.5, pp.313-316, 2000
Guler, S. Et Al. 2000. Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus. DIABETES OBESITY & METABOLISM , vol.2, no.5 , 313-316.
Guler, S., Cakir, B., Demirbas, B., Gursoy, G., Serter, R., & Aral, Y., (2000). Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus. DIABETES OBESITY & METABOLISM , vol.2, no.5, 313-316.
Guler, S Et Al. "Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus," DIABETES OBESITY & METABOLISM , vol.2, no.5, 313-316, 2000
Guler, S Et Al. "Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus." DIABETES OBESITY & METABOLISM , vol.2, no.5, pp.313-316, 2000
Guler, S. Et Al. (2000) . "Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus." DIABETES OBESITY & METABOLISM , vol.2, no.5, pp.313-316.
@article{article, author={S Guler Et Al. }, title={Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus}, journal={DIABETES OBESITY & METABOLISM}, year=2000, pages={313-316} }